CJC-1295 + Ipamorelin
otherGHRH analog + GH secretagogue
Stacks & Combinations
Research status · Not FDA-approved
Not FDA-approved as a combination. Both components are discussed in GH-axis and wellness settings, but neither has an approved broad body-composition indication.
CJC-1295 plus ipamorelin is a widely discussed secretagogue pairing intended to stimulate the body's own growth-hormone pulses. Human evidence for wellness use is limited, and the combination requires clinician-level risk review.
How it works
CJC-1295 acts as a GHRH analog, while ipamorelin activates the growth-hormone secretagogue receptor. The pairing is discussed as complementary GH-axis stimulation.
Common components
Commonly discussed purpose
- Sleep/recovery discussion
- Body-composition discussion
Commonly discussed use cases
- Sleep and recovery discussion
- Body-composition discussion
- GH-axis lab monitoring discussion
Supposed / potential benefits
- Subjective community reports are not a substitute for controlled evidence
- Objective benefit should be evaluated with clinician-selected markers
Common side effects
- Water retention
- Tingling or numbness
- Headache
- Hunger changes
- Glucose effects
- Injection-site reactions
Warnings & contraindications
- Not FDA-approved; long-term safety is not established
- Raising GH/IGF-1 may be inappropriate with certain cancer, glucose, or endocrine histories
- Unregulated products carry purity and dosing risks
Typical timing considerations
No established or recommended regimen. Community timing claims should not replace clinician instructions.
Administration route
Subcutaneous injection
Questions to ask your clinician
- What baseline IGF-1, glucose, and contraindication screening do you recommend?
- How would we decide whether this is helping?
- What symptoms or lab changes would make us stop?
Commonly tracked in Reta
Tracking fields organize user-entered, clinician-directed routines — Reta never recommends or computes doses.
Track this in Reta
Beta members get a ready-made tracker for CJC-1295 + Ipamorelin — schedule, dose log, injection-site rotation, reminders, and check-ins — for organizing a clinician-directed routine. Personal tracking is available to everyone during the Public Beta.
Reta is a tracking and education tool — not a medical provider. Nothing here is a diagnosis, treatment, prescription, or dosing recommendation. Peptides and medications should only be used under the direction of a licensed clinician. Talk to a qualified clinician before starting, stopping, combining, or changing anything. Many compounds below are not FDA-approved for human use; some are investigational or sold through unregulated channels where purity and dosing are not guaranteed.